Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trimedyne says judgement against Bard encouraging:

This article was originally published in Clinica

Executive Summary

Trimedyne, which is suing CR Bard over the latter's alleged failure to fulfill a ten-year marketing agreement signed in 1991, says that a District Court judgement affirms its claim and expects a trial date to be set soon. Trimedyne is suing Bard for $72 million. The poor relationship between the two companies was exacerbated when Bard signed a similar agreement with Surgical Laser Technologies in 1994. This prompted a $62 million suit from SLT after Bard allegedly reneged on the SLT deal citing its previous agreement with Trimedyne (see Clinica No 632, p 15).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT083312

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel